Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC
15/04/2021
0:00
15:06
Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
Mais episódios de "JAMA Oncology Author Interviews"
Não percas um episódio de “JAMA Oncology Author Interviews” e subscrevê-lo na aplicação GetPodcast.